IBJNews

First Financial changes local leadership as it expands

Back to TopCommentsE-mailPrintBookmark and Share

The bank known for its oddball, pale-yellow signage is reshuffling management locally as it continues a statewide expansion.

Cincinnati-based First Financial Bancorp, which has only been in the metropolitan Indianapolis market since 2008, has tapped former Old National Bank executive Steve Spicer as Indianapolis market president.

steve spicer first financial mug Steve Spicer

Most recently, Spicer was a senior vice president of corporate banking at  Evansville-based Old National. His 30-year career also includes roles at Huntington Bank, Fifth Third Bank and JPMorgan Chase.

Spicer succeeds Mary Jo Kennelly, who moved to a senior vice president role at First Financial.

Meanwhile, Kevin Langford, who is president of Indiana operations and of the bank’s consumer division in three states, has moved to Carmel from Cincinnati.

Langford said he wants to have tighter connections with the bank’s growing footprint in the state. Last month, First Financial announced it is entering the Fort Wayne market, with an eye on commercial lending and residential mortgages.

The bank also has offices in northwestern Indiana, including Lake County. Its 2009 purchase of branches from the failed Irwin Union Bank gave it a presence in the Columbus area as well as in Franklin, Carmel and Avon.

First Financial’s most substantial retail move into the metro area came in 2011, when it bought 22 branches of Michigan-based Flagstar Bank.

Given how crowded the Indianapolis banking market has become, “the smart move is to get somebody who will sell you their locations,” said Steve Schenck, who formerly ran Regions Bank’s local operations and is now a principal at The Schenck Group at Merrill Lynch..

First Financial has more than 110 employees in the metro area and has regional offices at 433 N. Capitol Ave.

Langford declined to elaborate on additional growth plans this year.  “We’d like to see significant growth and become one of the largest players in Indianapolis," he said.

The bank ranked 14th-biggest locally in IBJ’s most recent Book of Lists.

First Financial Bancorp has about $6.5 billion in assets, or roughly the size of Indiana National Bank when it was acquired in the early 1990s by NBD.

By comparison, First Financial’s fellow Cincinnati-based competitor, Fifth Third, has assets of $103 billion.

The ever-more-crowded metro bank market hasn’t deterred outsiders from trying to get a piece of the pie—even smaller players.

For example, Warsaw-based Lake City Bank recently built a retail branch in Fishers, after having set up an office in Carmel a few years earlier.  It’s closing in on $80 million in deposits locally.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. So, Pence wants the federal government to ignore the 2008 law that allows children from these countries to argue for asylum in front of a judge. How did this guy become governor? And how is that we'll soon be subjected to repeatedly seeing him on TV being taken seriously as a presidential candidate? Am I in Bizzaro-U.S.A.?

  2. "And the most rigorous studies of one-year preschool programs have shown short-term benefits that fade out in a few years or no benefits at all." So we are going down a path that seems to have proven not to work very well. Right intention, wrong approach?

  3. Well for Dunkin Donuts it might say that even a highly popular outlet can't make a poorly sited location work. That little strip has seen near constant churn for years.

  4. Years ago, the Pharmaceutical and Medical Device companies shifted their research investment away from Medical Institutions to focus more on private research centers, primarily because of medical institution inefficiencies in initiating clinical studies and their inability/commitment to enroll the needed number of patients in these studies. The protracted timelines of the medical institutions were prompting significant delays in the availability of new drug and medical device entities for patients and relatedly, higher R and D expenditures to the commercial industry because of these delays. While the above stated IU Health "ratio is about $2.50 in federal funding for every $1 in industry funding", the available funding is REVERSED as commercial R and D (primarily Phase I-IV clinical work)runs $2.50 to $1 for available federal funding ($76.8B to $30.9B in 2011). The above article significatly understated the available R and D funding from industry......see the Pharma and Medical Device industry websites. Clearly, if medical institutions like IU Health wish to attract more commercial studies, they will need to become more competitive with private clinical sites in their ability to be more efficient and in their commitment to meet study enrollment goals on time. Lastly, to the reference to the above Washington Post article headlined “As drug industry’s influence over research grows, so does the potential for bias", lacks some credibility as both FDA and Institutional Institutional Review Boards must approve the high proportion of these studies before studies are started. This means that both study safety and science must be approved by both entities.

  5. ChIeF and all the other critics – better is better no matter what. Get over it; they are doing better despite you ?

ADVERTISEMENT